Health Catalyst, Inc

Health Catalyst, Inc

1.27
EUR
0.00
(0.00%)
-2.43EPS
118.04MMarket Cap
Mar 02Next Earn
Health Catalyst, Inc
GETTEX:2YP
(Gettex)

Recent

price

1.27

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
2.63
4.05
8.27
4.78
5.09
5.14
5.25
5.09
4.45
3.72
Revenue per Share
-1.69
-2.23
-3.21
-2.91
-3.23
-2.56
-2.09
-1.15
-2.55
-2.76
Basic EPS, GAAP
-1.45
-1.53
-1.93
-0.89
-0.74
-0.74
-0.63
0.21
-0.01
0.34
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-7.61
-11
5.47
6.37
9.92
7.69
6.29
5.7
3.41
1.91
Book Value per Share
-8.59
-11.94
4.67
1.6
4.7
2.66
1.76
0.3
-0.57
1.11
Tangible Book Value per Share
28
28
19
40
47
54
56
60
70
73
Basic Weighted Avg Shares
73
113
155
189
242
276
296
307
311
272
Sales/Revenue/Turnover
-62.31
-53.38
-35.41
-50.9
-59.38
-50.68
-33.79
-18.79
-13.74
-10.69
Operating Margin (%)
6
7
9
19
38
48
42
41
51
46
Depreciation Expense
-47
-62
-60
-115
-153
-137
-118
-70
-178
-202
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-64.36
-55.06
-38.79
-60.91
-63.33
-49.74
-39.92
-22.67
-57.2
-74.24
Profit Margin (%)
41
25
216
242
415
345
304
140
80
55
Working Capital
10
23
50
193
201
245
246
167
166
12
LT Debt
-259
-375
201
276
522
425
367
365
246
146
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-48.25
-38.39
-29.02
-29.84
-18.99
-58.26
-84.64
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
5
5
4
LT Borrowings
152
152
- -
LT Finance Leases
13
13
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
74
75
76
Market Capitalization
93
149
134

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
182
248
133
Cash, Cash Equivalents & STI
109
103
79
Accounts Receivable, Net
59
42
41
Inventories
- -
- -
- -
Total Current Liabilities
108
92
78
Payables & Accruals
28
27
23
ST Debt
5
5
4
Deferred Revenue
70
43
42

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
4.73%
-32.7%
Free Cash Flow
- -
-48.25%
-108.38%
Net Income, GAAP
- -
24.76%
156.07%
Sales/Revenue/Turnover
- -
10.9%
1.48%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
75
76
76
80
307
2025
79
81
76
75
311
2026
71
70
56
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.35
-0.23
-0.24
-0.33
-1.15
2025
-0.35
-0.59
-0.32
-1.28
-2.55
2026
-1.53
-0.55
0.54
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Health Catalyst, Inc. (Nasdaq: HCAT) Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States, enabling clinical, financial, and operational improvements through its cloud-based Health Catalyst Ignite ecosystem; the company offers a Data Operating System (DOS) platform that integrates disparate data sources into a unified patient view, analytics applications for population health management, clinical decision support, revenue cycle improvement, patient safety, regulatory compliance, and cybersecurity; professional services including consulting, implementation support, and tech-enabled managed services; patient engagement solutions such as Twistle Patient Engagement, Lumeon Care Orchestration for optimizing clinician time and care pathways, and AI-powered tools for cyber protection and risk management. Founded in 2008 and headquartered in South Jordan, Utah, Health Catalyst serves over 1,000 healthcare organizations including hospitals, health systems, and providers, targeting value-based care, patient activation, and cost reduction across North America with expanding capabilities in the United Kingdom. Recent developments include the August 2024 completion of its acquisition of Lumeon Limited to enhance care orchestration with advanced analytics and AI integration; the November 2024 signing of a definitive agreement to acquire Intraprise Health, a top-rated cybersecurity firm, to bolster enterprise risk management and data protection; and the January 2025 agreement to acquire Upfront Healthcare Services, expected to close in Q1 2025, adding patient activation, scheduling, and personalized marketing analytics to strengthen access optimization and care transitions.

Company News

  • Health Catalyst, Inc. (HCAT) Q3 2026 Earnings Call Transcript

  • What Health Catalyst (HCAT) Said on Its Q3 Earnings Call

  • Health Catalyst (HCAT) Reports Q3 Loss, Beats Revenue Estimates

  • Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings

  • Health Catalyst Reports Third Quarter 2026 Results

  • Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026

  • Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

  • Health Catalyst Strengthens Its Board with the Appointment of Tami Reller

  • Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President

  • Hsbc Holdings PLC Invests $809,000 in Health Catalyst, Inc. $HCAT

  • Health Catalyst to Participate in Upcoming Investor Conference

  • Critical Survey: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)

  • Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Rating of “Hold” from Analysts

  • Health Catalyst (NASDAQ:HCAT) and Lynx Global Digital Finance (OTCMKTS:CNONF) Head-To-Head Review

  • Health Catalyst Q2 Earnings Call Highlights

  • Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

  • Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

  • Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

  • Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

  • Health Catalyst Reports Second Quarter 2026 Results